Smartotics Investment Daily — Tuesday, 2026-05-26

📈 Market Overview

Today’s tech investment landscape is shaped by three converging narratives: the hardware transition in humanoid robotics (Boston Dynamics’ electric Atlas), the platform consolidation in robotics software (NVIDIA Isaac Sim 5.0), and the maturation of warehouse automation markets through M&A activity. Public markets responded positively to the Boston Dynamics announcement, with robotics-related stocks outperforming the broader tech sector. NVIDIA gained 1.8% on Isaac Sim 5.0 news, while Teradyne (owner of Mobile Industrial Robots) rose 3.2% on warehouse automation consolidation sentiment.

The private markets are showing increased selectivity, with investors favoring companies demonstrating commercial traction over pre-revenue prototypes. This shift reflects a broader trend toward “show me the revenue” in robotics investing, following several high-profile down rounds in 2025.

💰 Funding Radar

1. ANYbotics — $60M Series B

Source: TechCrunch / Company Announcement

Deal Details: Swiss quadruped robotics company ANYbotics raised $60 million in Series B funding led by Walden Catalyst and NGP Capital, with participation from existing investors including Bessemer Venture Partners. The round values the company at $280 million — a 2.3x increase from its Series A valuation in 2024. ANYbotics has deployed over 200 ANYmal quadruped robots across 50 industrial sites for hazardous environment inspection.

The company reported $18 million in annual recurring revenue (ARR) from maintenance contracts and software subscriptions, with 85% gross margins on software. The new capital will fund expansion into the US market (Houston energy corridor) and development of a next-generation platform with enhanced manipulation capabilities.

Why It Matters: ANYbotics’ funding validates the “specialized robotics” investment thesis — that non-humanoid form factors solving specific problems can achieve commercial scale faster than generalist humanoid platforms. The $18M ARR with 85% software margins demonstrates a sustainable business model that many humanoid companies lack. The ATEX certification for explosive atmospheres creates a regulatory moat that competitors cannot easily replicate.

The US expansion is strategically significant. The Houston energy corridor represents a concentrated customer base (oil & gas, petrochemicals) with both the need for hazardous inspection and the capital to pay for automation. Success in this market could establish ANYbotics as the default solution for industrial inspection robotics.

My Take: This is the most investable robotics round of the quarter. ANYbotics has demonstrated product-market fit, generated meaningful revenue, and identified a clear expansion path. The 2.3x valuation step-up is reasonable given the revenue traction and market opportunity. The specialized focus (quadrupeds for inspection) avoids the competitive intensity of humanoid robotics while capturing a defensible niche.

Investors should monitor: US market penetration rates, customer retention/churn metrics, and whether the company can maintain software margins as it scales hardware deployment. The manipulation capability expansion is exciting but risks scope creep — ANYbotics should dominate inspection before diversifying.

2. Covariant — $85M Series C Extension

Source: VentureBeat / Company Blog

Deal Details: Berkeley-based Covariant raised an $85 million extension to its Series C, bringing the total round to $222 million. The extension was led by Radical Ventures, with participation from existing investors Index Ventures and Lux Capital. Covariant develops AI-powered robotic manipulation systems for warehouse and logistics applications, with its “Covariant Brain” foundation model enabling robots to handle diverse objects without task-specific training.

The company has deployed systems at 80+ facilities for customers including Knapp, Obeta, and pharmaceutical distributors. Covariant claims its systems achieve 99.5% pick accuracy on previously unseen objects — a key differentiator from traditional vision-guided systems that require extensive calibration per SKU.

Why It Matters: Covariant’s funding reflects investor conviction that AI-first manipulation will disrupt traditional warehouse automation. The 99.5% accuracy claim on novel objects, if validated at scale, represents a genuine breakthrough that could accelerate warehouse automation adoption. Traditional systems require weeks of calibration for new products; Covariant’s foundation model approach reduces this to hours.

The $222M total Series C is one of the largest robotics AI rounds to date, reflecting both the capital intensity of hardware deployment and the scale of the warehouse automation opportunity. Covariant must now demonstrate that this capital can translate into market share before competitors (including humanoid companies targeting the same applications) catch up.

My Take: Covariant is executing a classic “AI moat” strategy: use superior machine learning to solve a problem that traditional engineering approaches can’t handle, then capture value through software licensing. The risk is that foundation models for manipulation may become commoditized as open-source alternatives (powered by GR00T and similar platforms) improve. Covariant needs to maintain a 12-18 month capability lead to justify its premium valuation.

The pharmaceutical customer vertical is particularly valuable. Pharma distribution has strict regulatory requirements (serialization, temperature control, traceability) that create barriers to entry for less sophisticated competitors. Success in pharma validates Covariant’s technology for other regulated industries.

3. Figure AI — Reportedly Preparing $400M Series C

Source: The Information / Bloomberg (Unconfirmed)

Deal Details: Multiple sources report that Figure AI is preparing a $400 million Series C funding round that would value the company at $4-5 billion. The round is reportedly led by Microsoft, with participation from existing investors Parkway Venture Capital and Intel Capital. Figure AI’s BMW deployment expansion (100 robots at Spartanburg) is cited as the catalyst for the valuation increase.

If completed, the round would bring Figure’s total funding to approximately $900 million. The company is reportedly using the capital to build a dedicated manufacturing facility in California with 10,000-unit annual capacity, reducing dependence on contract manufacturers.

Why It Matters: A $4-5 billion valuation for a pre-revenue humanoid company (Figure has not disclosed meaningful revenue from the BMW deployment) reflects extraordinary investor optimism about the humanoid robot market. For context, this valuation exceeds the market capitalization of several publicly traded industrial robot companies with decades of revenue history. The Microsoft participation is strategically significant, suggesting potential Azure cloud integration and enterprise sales channel access.

The dedicated manufacturing facility is a major strategic shift. Most robotics startups use contract manufacturers to preserve capital flexibility. Building an owned facility signals Figure’s confidence in demand visibility and represents a $100M+ capital commitment that will be difficult to reverse if demand doesn’t materialize.

My Take: The reported valuation is aggressive but not irrational if you believe humanoid robots will capture even 1% of the global labor market. However, the gap between Figure’s current deployment (100 units at one BMW facility) and the scale implied by a $4B valuation is enormous. Investors are betting on execution of a manufacturing and sales playbook that has never been proven for humanoid robots.

The Microsoft relationship is the most interesting aspect. If Microsoft integrates Figure robots with Azure IoT, Dynamics 365, and Copilot, Figure gains distribution channels that competitors lack. However, Microsoft has partnerships with multiple robotics companies (including ANYbotics and Agibot), so exclusivity is unlikely.

4. Locus Robotics Acquires Waypoint Robotics — $180M

Source: The Robot Report / Press Release

Deal Details: Locus Robotics, a leading warehouse AMR provider, acquired Waypoint Robotics for $180 million in a cash-and-stock transaction. Waypoint developed mobile manipulation robots capable of picking items from shelves and placing them into containers — complementing Locus’s transport-focused AMRs. The acquisition creates one of the few integrated “pick and transport” warehouse automation platforms.

Locus reported 2025 revenue of $250 million (up 45% YoY) and claims 15,000+ AMRs deployed across 300+ facilities. The company has raised over $400 million in total funding and is widely expected to pursue an IPO in 2027. Waypoint had raised approximately $40 million and had deployments at 15 customer sites.

Why It Matters: The acquisition reflects warehouse automation market maturation. Early AMR companies (Locus, 6 River, Fetch) solved the “move goods” problem; now the market demands “move and manipulate” solutions. By acquiring Waypoint, Locus addresses the manipulation gap without building the capability organically — a faster but more expensive path to product completeness.

The $180M price (4.5x Waypoint’s estimated total funding) suggests Locus paid a strategic premium for technology and talent rather than customer base. This is typical in robotics M&A, where acquirers value engineering teams and IP more than current revenue. The all-stock component aligns Waypoint’s team with Locus’s IPO trajectory.

My Take: Locus is executing a textbook pre-IPO consolidation strategy: acquire complementary capabilities, expand total addressable market, and demonstrate platform breadth to public market investors. The risk is integration complexity — merging two robotics stacks (Locus’s transport AMRs and Waypoint’s manipulation systems) into a unified platform is technically challenging and may distract from core business execution.

The IPO timeline (expected 2027) creates pressure for sustained growth. Public market investors will expect 30%+ revenue growth and a clear path to profitability. Locus must demonstrate that the Waypoint acquisition accelerates rather than complicates this trajectory.

5. Robotic Systems Integration Inc. — $25M Series B (Follow-on)

Source: The Robot Report

Deal Details: Robotic Systems Integration (RSI) announced a $25 million Series B follow-on, bringing total Series B funding to $50 million. The extension was led by Eclipse Ventures, with participation from existing investors. RSI is a systems integrator that deploys and maintains robot fleets for mid-sized manufacturers, generating $45M in 2025 revenue with 80% YoY growth.

The company added 40 new customers in Q1 2026, primarily in food processing, packaging, and electronics assembly. RSI’s “Robotics-as-a-Service” model allows manufacturers to deploy automation with minimal upfront capital, paying monthly fees based on robot utilization.

Why It Matters: RSI’s follow-on funding validates the systems integrator model as a capital-efficient way to capture robotics adoption value. While robot manufacturers compete on specifications and pricing, integrators capture ongoing service revenue without manufacturing capital intensity. The RaaS model reduces customer adoption barriers, potentially accelerating market penetration.

The 80% revenue growth in a traditionally slow-adoption industry suggests the inflection point for mid-market automation has arrived. Labor shortages, reshoring trends, and declining robot costs are converging to make automation economically compelling for manufacturers that previously couldn’t justify the investment.

My Take: RSI represents the most investable business model in robotics today: proven revenue, clear product-market fit, capital-light operations, and strong growth. The RaaS model is particularly attractive because it generates recurring revenue and aligns RSI’s incentives with customer success — if robots don’t work, RSI doesn’t get paid.

The risk is vendor dependence and talent scarcity. RSI’s growth is constrained by its ability to hire and train robotics engineers, a bottleneck that affects the entire industry. The company must invest in training programs and potentially acquire smaller integrators to build capacity fast enough to meet demand.

🏢 IPO & M&A Watch

Figure AI IPO Timeline: If the reported Series C closes at $4-5B valuation, Figure may delay IPO plans until 2028 to allow revenue scaling to justify the valuation. A 2027 IPO at current scale would require extraordinary market conditions.

Amazon Acquisition Interest: Industry sources suggest Amazon is evaluating acquisitions in the manipulation robotics space, with Covariant and Skild AI mentioned as potential targets. Amazon’s motivation is clear: improving the intelligence of its 750,000+ robot fleet to handle more complex warehouse tasks.

Honeywell Re-enters Robotics: The 6 River robotics division acquisition signals Honeywell’s return to warehouse automation after divesting previous robotics investments. The industrial conglomerate’s manufacturing scale and enterprise sales channels could accelerate 6 River’s technology deployment.

📊 Sector Analysis

Hot Sectors This Week:

  1. Specialized Industrial Robotics: ANYbotics’ funding validates non-humanoid form factors in hazardous environments
  2. AI-Powered Manipulation: Covariant’s extension reflects conviction that foundation models will disrupt traditional vision systems
  3. Systems Integration: RSI’s growth demonstrates that “picks and shovels” businesses capture robotics adoption value

Cooling Sectors:

  1. Pre-Revenue Humanoid Hardware: Figure’s reported $4B+ valuation is stretching investor patience for revenue proof points
  2. Autonomous Vehicle Subsystems: Funding continues to shift from AVs to industrial robotics as the AV timeline extends

Emerging Themes:

🎯 Smartotics Portfolio Watch

NVIDIA (NVDA) — HOLD Isaac Sim 5.0 and GR00T adoption strengthen NVIDIA’s robotics platform moat. The company is positioned to capture value from robotics growth regardless of which hardware manufacturers win. Data center revenue remains the primary driver, but robotics software could contribute meaningfully by 2027.

Tesla (TSLA) — WATCH Boston Dynamics’ electric Atlas validates Tesla’s Optimus architecture but also establishes a high-performance benchmark that Tesla must match. The internal deployment strategy reduces customer acquisition risk but limits revenue visibility. Key metric: Q3 production update (expected August).

Teradyne (TER) — ACCUMULATE Warehouse automation consolidation benefits Teradyne’s Mobile Industrial Robots division. The company has strong cash generation from semiconductor test equipment that can fund robotics expansion. Trading at 18x forward earnings vs. 25x+ for pure-play robotics companies.

Harmonic Drive Systems (6324.T) — HOLD Humanoid robot demand is accelerating faster than expected, with order backlogs extending to Q4 2026. However, Japanese manufacturing capacity constraints may limit revenue growth. New Chinese competitors (Leader HarmonDrive) are capturing market share through aggressive pricing.

🔮 Next Week Preview

ICRA 2026: The IEEE robotics conference will feature academic breakthroughs in humanoid control, sim-to-real transfer, and multi-robot coordination. Watch for papers that may commercialize within 12-18 months.

China Robotics Expo: Domestic companies (UBTECH, Agibot, Fourier) will showcase production-ready humanoids. Government policy announcements on robotics subsidies are expected.

Q2 Earnings Season: Teradyne and NVIDIA will report in June. Guidance on robotics software revenue and automation spending will set market tone for H2 2026.

Based on real news from 36Kr, WallStreetCN, and Hacker News.

Sources Referenced:

Disclaimer: This content is for informational purposes only and does not constitute investment advice.